Home › Lupus › Texas › Arlington
Lupus clinical trials in Arlington, TX
3 studies for Lupus are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
RecruitingPhase 3
- Research Site, Colleyville · 10 mi away
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
RecruitingPhase 2
- Precision Comprehensive Clinical Research Solutions, Euless · 7 mi away
- Precision Comprehensive Clinical Research Solutions - Colleyville, Colleyville · 10 mi away
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
RecruitingPhase 3
- Sl0044 50718, Mansfield · 12 mi away
About Lupus
Lupus is an autoimmune disease that causes your immune system to attack your healthy tissues and cells. This can cause damage to many parts of your body.
More about Lupus on MedlinePlus
Lupus trials in other cities
- New York City, NY18 studies
- Houston, TX14 studies
- Durham, NC12 studies
- Washington, DC11 studies
- Miami, FL10 studies
- Oklahoma City, OK9 studies
- San Diego, CA8 studies
- Tampa, FL8 studies
- Boston, MA8 studies
- Chicago, IL8 studies
- Philadelphia, PA8 studies
- Santa Monica, CA7 studies
Other studies in Arlington
- Steatotic Liver Disease7 studies
- Non-Small Cell Lung Cancer4 studies
- Non-Muscle Invasive Bladder Cancer4 studies
- Chronic Kidney Disease4 studies
- High Blood Pressure4 studies
- Rheumatoid Arthritis4 studies
- Sjögren's Disease4 studies
- Breast Cancer3 studies
- Ulcerative Colitis3 studies
- Bladder Cancer3 studies
- Cirrhosis3 studies
- Pneumococcal Infections3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.